| Pidolic-acid | hsa00670 | One carbon pool by folate | 3.07E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | |
| Pidolic-acid | hsa00730 | Thiamine metabolism | 3.07E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
| Pidolic-acid | hsa03018 | RNA degradation | 4.01E-02 | 1 | Q13901 | C1D | More | |
| Pidolic-acid | hsa03020 | RNA polymerase | 6.37E-07 | 3 | P30876, Q9GZM3, P52435 | POLR2B, POLR2J2, POLR2J | More | |
| Pidolic-acid | hsa03450 | Non-homologous end-joining | 3.65E-02 | 1 | P13010 | XRCC5 | More | |
| Pidolic-acid | hsa04015 | Rap1 signaling pathway | 2.41E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04020 | Calcium signaling pathway | 1.74E-02 | 3 | Q08828, P0DP23, P51828 | ADCY1, CALM1, ADCY7 | More | |
| Pidolic-acid | hsa04022 | cGMP-PKG signaling pathway | 2.80E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04024 | cAMP signaling pathway | 1.45E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04060 | Cytokine-cytokine receptor interaction | 2.29E-04 | 4 | P01584, Q13651, Q8NHW4, P13500 | IL1B, IL10RA, CCL4L2, CCL2 | More | |
| Pidolic-acid | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.99E-04 | 3 | P13500, Q8NHW4, Q13651 | CCL2, CCL4L2, IL10RA | More | |
| Pidolic-acid | hsa04062 | Chemokine signaling pathway | 1.59E-03 | 4 | Q8NHW4, P13500, Q08828, P51828 | CCL4L2, CCL2, ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04064 | NF-kappa B signaling pathway | 9.53E-03 | 2 | P01584, Q8NHW4 | IL1B, CCL4L2 | More | |
| Pidolic-acid | hsa04114 | Oocyte meiosis | 2.41E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04120 | Ubiquitin mediated proteolysis | 3.77E-02 | 2 | Q13620, Q14139 | CUL4B, UBE4A | More | |
| Pidolic-acid | hsa04213 | Longevity regulating pathway - multiple species | 4.79E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.41E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04270 | Vascular smooth muscle contraction | 1.18E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04371 | Apelin signaling pathway | 1.74E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04540 | Gap junction | 3.12E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04620 | Toll-like receptor signaling pathway | 1.35E-03 | 2 | P01584, Q8NHW4 | IL1B, CCL4L2 | More | |
| Pidolic-acid | hsa04621 | NOD-like receptor signaling pathway | 2.49E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa04623 | Cytosolic DNA-sensing pathway | 4.04E-04 | 2 | P01584, Q8NHW4 | IL1B, CCL4L2 | More | |
| Pidolic-acid | hsa04625 | C-type lectin receptor signaling pathway | 3.92E-02 | 2 | P01584, P0DP23 | IL1B, CALM1 | More | |
| Pidolic-acid | hsa04630 | JAK-STAT signaling pathway | 3.92E-02 | 2 | P23458, Q13651 | JAK1, IL10RA | More | |
| Pidolic-acid | hsa04657 | IL-17 signaling pathway | 1.16E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa04668 | TNF signaling pathway | 1.99E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa04713 | Circadian entrainment | 4.30E-03 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04720 | Long-term potentiation | 4.79E-02 | 2 | P0DP23, Q08828 | CALM1, ADCY1 | More | |
| Pidolic-acid | hsa04723 | Retrograde endocannabinoid signaling | 4.79E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04724 | Glutamatergic synapse | 4.79E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04740 | Olfactory transduction | 4.99E-02 | 1 | Q9H255 | OR51E2 | More | |
| Pidolic-acid | hsa04742 | Taste transduction | 2.02E-02 | 1 | P30939 | HTR1F | More | |
| Pidolic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 2.43E-04 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04911 | Insulin secretion | 3.12E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04912 | GnRH signaling pathway | 5.77E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04913 | Ovarian steroidogenesis | 2.39E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04915 | Estrogen signaling pathway | 2.41E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04916 | Melanogenesis | 2.10E-03 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04921 | Oxytocin signaling pathway | 1.18E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04923 | Regulation of lipolysis in adipocytes | 1.19E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04925 | Aldosterone synthesis and secretion | 5.77E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04927 | Cortisol synthesis and secretion | 2.39E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.16E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa04934 | Cushing syndrome | 4.79E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04970 | Salivary secretion | 1.35E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04971 | Gastric acid secretion | 1.35E-03 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | |
| Pidolic-acid | hsa04972 | Pancreatic secretion | 1.75E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa04976 | Bile secretion | 7.88E-04 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | |
| Pidolic-acid | hsa04979 | Cholesterol metabolism | 1.19E-02 | 2 | P38571, P61916 | LIPA, NPC2 | More | |
| Pidolic-acid | hsa05016 | Huntington disease | 2.47E-03 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | |
| Pidolic-acid | hsa05032 | Morphine addiction | 2.39E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa05133 | Pertussis | 2.39E-02 | 2 | P0DP23, P01584 | CALM1, IL1B | More | |
| Pidolic-acid | hsa05135 | Yersinia infection | 2.99E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa05142 | Chagas disease | 5.60E-03 | 3 | P01584, Q08828, P13500 | IL1B, ADCY1, CCL2 | More | |
| Pidolic-acid | hsa05144 | Malaria | 1.16E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa05152 | Tuberculosis | 8.75E-03 | 4 | P0DP23, P23458, Q13651, P01584 | CALM1, JAK1, IL10RA, IL1B | More | |
| Pidolic-acid | hsa05163 | Human cytomegalovirus infection | 4.84E-07 | 8 | P0DP23, P13500, Q8NHW4, Q08828, P51828, P23458, P01584, Q13651 | CALM1, CCL2, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, IL10RA | More | |
| Pidolic-acid | hsa05164 | Influenza A | 8.23E-03 | 4 | P01584, P23458, Q9UBU9, P13500 | IL1B, JAK1, NXF1, CCL2 | More | |
| Pidolic-acid | hsa05168 | Herpes simplex virus 1 infection | 2.70E-02 | 4 | P01584, Q9UBU9, P23458, Q6P280 | IL1B, NXF1, JAK1, ZNF529 | More | |
| Pidolic-acid | hsa05225 | Hepatocellular carcinoma | 3.04E-02 | 2 | P37173, Q92922 | TGFBR2, SMARCC1 | More | |
| Pidolic-acid | hsa05323 | Rheumatoid arthritis | 1.82E-02 | 1 | P13500 | CCL2 | More | |
| Pidolic-acid | hsa05414 | Dilated cardiomyopathy | 3.92E-02 | 2 | Q08828, P51828 | ADCY1, ADCY7 | More | |
| Pidolic-acid | hsa05418 | Fluid shear stress and atherosclerosis | 2.49E-02 | 1 | P13500 | CCL2 | More | |
